Advertisement

Topics

Sumitomo Corporation of America Company Profile

15:40 EST 23rd November 2017 | BioPortfolio

Sumitomo Corporation of America (SCOA) is a wholly owned subsidiary of Sumitomo Corporation (SC), an integrated trading and investment enterprise engaged in multifaceted business activities, which include selling a variety of domestic products and services, conducting import/ export and trilateral business transactions, providing domestic and international business investment, and participating in numerous other profitable activities facilitated by its global network and the relationships of trust built with corporate business partners and consumers in various industrial sectors around the world. SC's Life Sciences Group has more than 40 years of proven pharmaceutical experience with over $400 million in Pharma sector revenue and 200 experienced professionals strategically located in New York, London, Tokyo, Osaka, Milan, Barcelona, Shanghai and Mumbai. The Group has 10 pharma related affiliate companies, including SPI which conducts total outsourcing from R&D to Commercial Stage. SCOA's Life Sciences Unit provides a gateway for entry into the Japanese marketplace through distribution, licensing and joint ventures. Additionally, SCOA provides financing and venture debt instruments to life sciences companies through its subsidiary Oxford Finance Corporation. Sumitomo's unique positioning and its integrated and complimentary suite of service offerings provides bio venture companies with a opportunity to advance their business models through efficient and rapid penetration into the Japanese and other international markets. SCOA Life Sciences Unit is based in SCOA's New York headquarters. For more information about SCOA, visit www.sumitomocorp.com


News Articles [365 Associated News Articles listed on BioPortfolio]

Sumitomo to buy 20% stake in Sawai America for $211m

Sumitomo Corporation of Americas (SCOA) has agreed to acquire 20% interest in Sawai Pharmaceutical’s US subsidiary Sawai America (SAI) for around $211m.

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

M&As this week: Shanghai Pharmaceutical, Sapphire I (HK) Holdings, Sumitomo Corporation of America

Shanghai Pharmaceutical plans to acquire Cardinal Health China business from US-based healthcare company Cardinal Health for $1.2bn. The divestiture will...Read More... The post M&As this week: Sh...

Sumitomo Dainippon Pharma und Angelini geben Partnerschaft für die Kommerzialisierung von Latuda® (Lurasidon-Hydrochlorid) in Europa bekannt

Tokio und Rom (ots/PRNewswire) - Sumitomo Dainippon Pharma Co., Ltd. (Unternehmenssitz: Osaka, Japan; Präsident: Masayo Tada; im Folgenden "Sumitomo Dainippon Pharma") und Angelini S.p.A. (Unterneh.....

Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(Lurasidone Hydrochloride) in Europe

TOKYO and ROME, November 21, 2017 /PRNewswire/ -- Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter "Sumitomo Dainippon Pharma") and Angelini S.p....

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummarySumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive co...

PubMed Articles [510 Associated PubMed Articles listed on BioPortfolio]

The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel.

Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its 7(th) meeting (August 2016), the main obj...

The Paleo-Indian Entry into South America According to Mitogenomes.

Recent and compelling archaeological evidence attests to human presence ∼14.5 thousand years ago (Kya) at multiple sites in South America and a very early exploitation of extreme high-altitude Andea...

Organizational Issues, Structure, and Processes of Care in 257 ICUs in Latin America: A Study From the Latin America Intensive Care Network.

Latin America bears an important burden of critical care disease, yet the information about it is scarce. Our objective was to describe structure, organization, processes of care, and research activit...

Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries.

The increased availability of influenza surveillance data in recent years justifies an actual and more complete overview of influenza epidemiology in Latin America. We compared the influenza surveilla...

Embolic Stroke of Undetermined Source in Latin America: A Review.

Stroke is a major health concern throughout Latin America. As elsewhere, no precise cause can be determined for a substantial portion of strokes. In 6 studies since 2010 in the region, 16% to 43% of i...

Clinical Trials [307 Associated Clinical Trials listed on BioPortfolio]

Improving Perinatal Care in Latin America

Many obstetrical interventions used in Latin America, as in other parts of the world, have been shown to be ineffective or harmful, while effective interventions remain underutilized. This...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

This trial is conducted in Africa, Asia, Europe, South America and the United States of America (USA). The trial is planned to investigate the safety and efficacy of NovoSeven® in the ma...

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 with sitagliptin, as add-on to subject's own current oral...

Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America

Ibandronate is a third-generation biphosphonate with recognized antiresorptive efficacy by several international, randomized, double-blind, controlled trials. These studies have not includ...

Companies [1072 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Sumitomo Corporation of America (SCOA)

Sumitomo Corporation of America (SCOA) brings a global perspective to today's business opportunities as the largest subsidiary of Sumitomo Corporation (SC), one of Japan's major integrated trading and...

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Sumitomo Heavy Industries, Ltd.

Sumitomo Heavy Industries, Ltd. (TOKYO:6302) is a technology-oriented Japanese manufacturer of medical and industrial machinery. Its accelerator technology is widely used in the s...

Sumitomo Corporation Europe Limited

Sumitomo Corporation Europe is a principal subsidiary of Sumitomo Corporation, a leading integrated trading company with its headquarters in Japan, and as such we share in its key role in the exchange...

More Information about "Sumitomo Corporation of America" on BioPortfolio

We have published hundreds of Sumitomo Corporation of America news stories on BioPortfolio along with dozens of Sumitomo Corporation of America Clinical Trials and PubMed Articles about Sumitomo Corporation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sumitomo Corporation of America Companies in our database. You can also find out about relevant Sumitomo Corporation of America Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record